MX2025000164A - Aloinjertos placentarios humanos esteriles y metodos de produccion de los mismos - Google Patents
Aloinjertos placentarios humanos esteriles y metodos de produccion de los mismosInfo
- Publication number
- MX2025000164A MX2025000164A MX2025000164A MX2025000164A MX2025000164A MX 2025000164 A MX2025000164 A MX 2025000164A MX 2025000164 A MX2025000164 A MX 2025000164A MX 2025000164 A MX2025000164 A MX 2025000164A MX 2025000164 A MX2025000164 A MX 2025000164A
- Authority
- MX
- Mexico
- Prior art keywords
- human placental
- placental tissue
- dehydrated
- sterile
- allografts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3691—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Reproductive Health (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Pregnancy & Childbirth (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Un método para preparar aloinjertos placentarios humanos estériles al proporcionar un tejido placentario humano de un donador en un período de 24 horas a 72 horas posteriores al parto; remover cualquier sangre visible, coágulos de sangre y/o componentes sanguíneos del tejido placentario humano sin raspar o fregar el tejido placentario humano para conservar la integridad estructural del tejido placentario humano; lavar el tejido placentario humano en una solución isotónica en tanto que se mantiene la integridad estructural del tejido placentario humano; deshidratar el tejido placentario humano formando de esta manera el tejido placentario humano deshidratado; redimensionar el tejido placentario humano deshidratado en porciones de tejido placentario humano deshidratado que tienen tamaños predeterminados; y esterilizar las porciones de tejido placentario humano deshidratado del paso (e) formando de esta manera el aloinjerto placentario humano estéril. También se divulga un aloinjerto placentario humano estéril producido por el método.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263356628P | 2022-06-29 | 2022-06-29 | |
| US202263391032P | 2022-07-21 | 2022-07-21 | |
| US202263395426P | 2022-08-05 | 2022-08-05 | |
| NL2033318A NL2033318B1 (en) | 2022-10-14 | 2022-10-14 | Sterile human placental allografts and methods of making thereof |
| PCT/US2023/026447 WO2024006353A1 (en) | 2022-06-29 | 2023-06-28 | Sterile human placental allografts and methods of making thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2025000164A true MX2025000164A (es) | 2025-05-02 |
Family
ID=89381391
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2025000164A MX2025000164A (es) | 2022-06-29 | 2025-01-06 | Aloinjertos placentarios humanos esteriles y metodos de produccion de los mismos |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12285445B2 (es) |
| EP (2) | EP4442316B1 (es) |
| JP (1) | JP2025522893A (es) |
| AU (1) | AU2023297925A1 (es) |
| CA (1) | CA3260661A1 (es) |
| ES (1) | ES2993384T3 (es) |
| MX (1) | MX2025000164A (es) |
| WO (1) | WO2024006353A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023297923A1 (en) * | 2022-06-29 | 2025-01-16 | Biostem Technologies, Inc. | Micronized compositions for wound healing prepared from intact human amnion-chorion tissue having an intact intermediate spongy layer positioned there between |
| ES2993384T3 (en) * | 2022-06-29 | 2024-12-27 | Biostem Tech Inc | Sterile human placental allografts and methods of making thereof |
| USD1085425S1 (en) | 2022-11-18 | 2025-07-22 | Biostem Technologies, Inc. | Fenestrated human placental allograft |
| USD1085424S1 (en) * | 2022-11-18 | 2025-07-22 | Biostem Technologies, Inc. | Fenestrated human placental allograft |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6933326B1 (en) | 1998-06-19 | 2005-08-23 | Lifecell Coporation | Particulate acellular tissue matrix |
| US8372437B2 (en) | 2006-08-17 | 2013-02-12 | Mimedx Group, Inc. | Placental tissue grafts |
| WO2009033160A1 (en) | 2007-09-07 | 2009-03-12 | Surgical Biologics | Placental tissue grafts and improved methods of preparing and using the same |
| CZ301086B6 (cs) | 2007-10-17 | 2009-11-04 | Bio-Skin, A. S. | Sterilní autologní, allogenní nebo xenogenní implantát a zpusob jeho výroby |
| EP3744336B1 (en) | 2011-02-14 | 2025-01-01 | MiMedx Group, Inc. | Micronized placental tissue compositions and methods for making and using the same |
| US9486316B2 (en) | 2011-09-30 | 2016-11-08 | NuTech Spine, Inc. | Osteoconductive implants and methods of using same |
| US9943551B2 (en) | 2012-08-15 | 2018-04-17 | Mimedx Group, Inc. | Tissue grafts composed of micronized placental tissue and methods of making and using the same |
| US11116871B2 (en) * | 2015-09-17 | 2021-09-14 | Stimlabs Llc | Compositions derived from placenta and methods of producing the same |
| WO2017112934A1 (en) * | 2015-12-23 | 2017-06-29 | Lifenet Health | Decellularized placental membrane and methods of preparing and use thereof |
| WO2021101802A2 (en) | 2019-11-21 | 2021-05-27 | Bioventus, Llc . | Placental tissue particulate compositions and methods of use |
| EP4076557A1 (en) | 2019-12-17 | 2022-10-26 | Musculoskeletal Transplant Foundation | Viable tissue forms and methods for making and using same |
| ES2993384T3 (en) * | 2022-06-29 | 2024-12-27 | Biostem Tech Inc | Sterile human placental allografts and methods of making thereof |
| CA3260775A1 (en) * | 2022-06-29 | 2024-01-04 | Biostem Technologies, Inc. | Sterile human placental allografts having multiple clefts, openings and/or windows formed on them |
-
2023
- 2023-06-28 ES ES23744947T patent/ES2993384T3/es active Active
- 2023-06-28 CA CA3260661A patent/CA3260661A1/en active Pending
- 2023-06-28 EP EP24195379.3A patent/EP4442316B1/en active Active
- 2023-06-28 WO PCT/US2023/026447 patent/WO2024006353A1/en not_active Ceased
- 2023-06-28 AU AU2023297925A patent/AU2023297925A1/en active Pending
- 2023-06-28 EP EP23744947.5A patent/EP4358981B1/en active Active
- 2023-06-28 JP JP2025500179A patent/JP2025522893A/ja active Pending
- 2023-06-28 US US18/290,914 patent/US12285445B2/en active Active
-
2025
- 2025-01-06 MX MX2025000164A patent/MX2025000164A/es unknown
- 2025-04-17 US US19/181,975 patent/US20250387435A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4358981A1 (en) | 2024-05-01 |
| EP4442316A3 (en) | 2024-11-13 |
| JP2025522893A (ja) | 2025-07-17 |
| CA3260661A1 (en) | 2024-01-04 |
| EP4358981B1 (en) | 2024-10-30 |
| US20240408147A1 (en) | 2024-12-12 |
| US12285445B2 (en) | 2025-04-29 |
| EP4442316A2 (en) | 2024-10-09 |
| WO2024006353A1 (en) | 2024-01-04 |
| US20250387435A1 (en) | 2025-12-25 |
| AU2023297925A1 (en) | 2025-01-16 |
| EP4442316B1 (en) | 2026-01-28 |
| ES2993384T3 (en) | 2024-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2025000164A (es) | Aloinjertos placentarios humanos esteriles y metodos de produccion de los mismos | |
| MX2025000161A (es) | Aloinjertos placentarios humanos esteriles que tienen una pluralidad de hendiduras, aberturas y/o fenestraciones formadas en los mismos | |
| US7354702B2 (en) | Processing tissue to produce a biopolymer scaffold for tissue engineering | |
| CN102580153B (zh) | 一种制备脱细胞真皮基质医用组织补片的方法 | |
| KR102126140B1 (ko) | 고순도 콜라겐 입자의 제조 및 이의 용도 | |
| CA1076752A (en) | Arteries for use in heterologous transplants | |
| CN1090206A (zh) | 处理骨组织的方法以及相应的可移植的生物材料 | |
| CN105435307A (zh) | 天然组织来源的脱细胞联合脱钙骨材料及其制备方法 | |
| CN105879120A (zh) | 一种天然组织来源的肌腱联合骨脱细胞材料的制备方法 | |
| CN112999421A (zh) | 一种球形晶煅烧骨的制备方法 | |
| CN110743039A (zh) | 一种自体颅骨用于回植材料的制备方法 | |
| CN104511052A (zh) | 一种骨膜生物支架与异体种子细胞复合的培养方法 | |
| RU2721604C1 (ru) | Способ получения остеопластических биоматериалов из костной ткани | |
| KR101386322B1 (ko) | 자가 치아 뼈 이식재의 가공방법 | |
| CN102921034A (zh) | 猪脱细胞真皮基质包被胶原的复合敷料及其制备方法 | |
| CN108273135B (zh) | 一种骨软骨缺损修复材料及其制备方法 | |
| CN114796615B (zh) | 一种软骨脱细胞基质及其制备方法 | |
| CN105920671A (zh) | 神经移植物的制备方法及其产品 | |
| EP3110246B1 (de) | Verfahren zur konservierung von porcinem knorpelgewebe | |
| CN102872479A (zh) | 异种骨材料的脱脂、脱蛋白处理方法及异种骨移植替代材料的制备方法 | |
| CN105561391A (zh) | 异种移植软组织植入物及制造和使用的方法 | |
| CN106730001A (zh) | 一种脱细胞生物羊膜的制备方法 | |
| CN109908402A (zh) | 一种松质骨胶原塞及其制备方法 | |
| WO2019168428A1 (ru) | Способ очистки костного и кожного матриксов с использованием сверхкритического флюида | |
| RU2778615C1 (ru) | Трансплантат, способ аутотрансплантации костного мозга для стимуляции репаративной регенерации кости и устройство для осуществления трансплантации |